As global oncology races toward next-generation therapies, Avammune Therapeutics is betting on affordable, orally administered immunotherap...

The oral drug, pociredir, was being tested ⁠to treat sickle-cell ⁠disease, an inherited blood disorder that can trigger pain, anemia and or...

Toregem BioPharma has secured $5.3 million to advance its experimental tooth-regeneration drug, TRG035, into Phase II clinical trials. The ...

Scientists are exploring a new way to treat chronic nerve pain by focusing on mitochondria, the energy-producing parts of cells. Researcher...

Harvard-born idea doubles survival in trials, triggers pharma frenzy as cos race to target 'undruggable' proteins with next-gen glue therap...

A groundbreaking study reveals a new cause for sunburn's immediate pain. Scientists now believe damage to RNA, not DNA, triggers the rapid ...

Scientists are developing AI-designed molecular syringes. These syringes use modified bacterial proteins. They target specific cells for dr...

Cipla has secured USFDA approval to market a generic version of Abraxane, paclitaxel protein-bound particles for injectable suspension (100...

As per Bharat Biotech, the facility will tackle scientific challenges such as targeted gene expression, immune system modulation, and long-...

The current therapeutic options available to treat DMD are minimal and highly expensive treatment with costs shooting up to Rs 2-3 crore pe...

The researchers said it is possible that the continuing accumulation of mutations may set the stage for greatly altering the equilibrium an...

The study, published in the journal Nature Communications on Thursday, is the first to show evACE2 are capable of fighting the new SARS-CoV...

Researchers at Yale School of Medicine in the US noted that the molecule could lead to new treatments for COVID-19 in immunocompromised pat...

Studying the structure of the coronavirus will help the discovery of a vaccine, leading national and international therapeutics, who are tr...

Scientists at the Institute of Microbial Technology (IMTECH), Chandigarh, have for the first time in India developed indigenous technology ...

Proteins called broadly neutralising antibodies (bNAbs) are a promising key to the prevention of infection by HIV, the virus that causes AI...

In a cross-border acquisition in the Indian biotech space, the E1.1-bn French major, Merieux Alliance, has snapped up a 60% stake in Hydera...